There are also diferences regarding the use of new agents or combinations of adjuvant therapies as well as regarding the roles of other forms of treatment such as chemoradiotherapy, chemoimmunotherapy, intraperitoneal adjuvant therapy, and neoadjuvant chemotherapy 7.We consider that it is essential to understand the Colombian situation and thus determine the possible gaps in diagnosis and management of these patients that may exist in comparison with other countries.
Así mismo, hay diferencias en el uso de nuevos agentes o combinaciones en adyuvancia y el papel de otras modalidades de tratamiento como la quimiorradioterapia, quimioinmunoterapia y la terapia adyuvante intraperitoneal y la quimioterapia neoadyuvante 7.